Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorCentre intégré de santé et de services sociaux de l'Outaouais

About this trial

This study will evaluate whether a wearable robotic exoskeleton can improve mobility, balance, and walking in healthy older adults and in individuals living with Parkinson's disease, populations at high risk of falls and mobility limitations. Participants will attend two laboratory sessions. The first session includes clinical assessments, fitting and familiarization with the exoskeleton, and interviews to explore user perceptions. The second session involves performing functional mobility tasks (e.g., walking, standing, turning) with and without the exoskeleton and under different assistance levels, while movement is measured using wearable sensors.

The study will assess the immediate effects of the exoskeleton on mobility, compare assistance levels, identify which participants benefit most, and explore user experience and acceptability. Findings will help inform the development and implementation of assistive technologies to support mobility in healthy aging and in individuals with Parkinson's disease.

Eligibility criteria

Qualifiers

Ability to walk for at least 30 minutes with or without minimal aid

Diagnosis of idiopathic Parkinson's disease

Hoehn and Yahr stage 1 to 4

Disqualifiers

Height smaller than 152 cm

Severe vascular conditions of the lower limbs that may limit mobility or pose a risk.

Presence of any implantable or external life-sustaining medical device such as a pacemaker

Severe osteoporosis or high risk of fractures

Trial design

Treatments tested in this trial

  • Exoskeleton

Treatment groups

26 Participants
are divided into 1 treatment group